Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell × copanlisib × 1 year × Clear all

Sponsor

Conditions

Neoplasm Metastasis 5 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma 3 Breast Neoplasms 3 Ovarian Neoplasms 2 Multiple Myeloma 2 Lymphoma, Follicular 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Endometrial Neoplasms 2 Urinary Bladder Neoplasms 1 Ureteral Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid cancer, follicular 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Spinocerebellar Degenerations 1 Neoplasms 1 Mycosis Fungoides 1 Metastatic Castration-resistant Prostate Cancer 1 Malignant Solid Neoplasm 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Mantle-Cell 1 Hodgkin Disease 1 Fallopian Tube Neoplasms 1 Disease Progression 1 Colonic Neoplasms 1

Interventions

Cyclophosphamide 8 Biopsy 8 pembrolizumab 7 Specimen Handling 7 fludarabine 6 Whole-Body Irradiation 6 Magnetic Resonance Spectroscopy 6 Brentuximab Vedotin 6 Peripheral Blood Stem Cell Transplantation 5 Melphalan 5 fludarabine phosphate 4 duvelisib 4 10-propargyl-10-deazaaminopterin 4 ruxolitinib 3 X-Rays 3 Mycophenolic Acid 3 Immunoglobulin G 3 Gemcitabine 3 Etoposide 3 Disulfides 3 tazemetostat 2 sodium-iodide symporter 2 romidepsin 2 cemiplimab 2 belinostat 2 Sirolimus 2 Rituximab 2 Photons 2 Pharmacogenomic Variants 2 Nivolumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡